These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37121488)

  • 21. Blood culture utilization and epidemiology of antimicrobial-resistant bloodstream infections before and during the COVID-19 pandemic in the Indonesian national referral hospital.
    Sinto R; Lie KC; Setiati S; Suwarto S; Nelwan EJ; Djumaryo DH; Karyanti MR; Prayitno A; Sumariyono S; Moore CE; Hamers RL; Day NPJ; Limmathurotsakul D
    Antimicrob Resist Infect Control; 2022 May; 11(1):73. PubMed ID: 35590391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
    Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
    Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidrug resistant bacterial infections in severely ill COVID-19 patients admitted in a national referral and teaching hospital, Kenya.
    Mutua JM; Njeru JM; Musyoki AM
    BMC Infect Dis; 2022 Nov; 22(1):877. PubMed ID: 36418990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and mortality outcome of carbapenem- and colistin-resistant
    Balkhair A; Saadi KA; Adawi BA
    IJID Reg; 2023 Jun; 7():1-5. PubMed ID: 36936715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of Carbapenem and Colistin Resistant Gram-Negative Bacteria Colonizing Immunocompromised SARS-CoV-2 Patients Admitted to Some Libyan Hospitals.
    Slimene K; Ali AA; Mohamed EA; El Salabi A; Suliman FS; Elbadri AA; El-Fertas FF; El-Awjly A; Shokri SA; Rolain JM; Chouchani C
    Microbiol Spectr; 2023 Jun; 11(3):e0297222. PubMed ID: 37042782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis.
    Li J; Wang J; Yang Y; Cai P; Cao J; Cai X; Zhang Y
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):153. PubMed ID: 32962731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 and Chlamydia pneumoniae co-infection: A review of the literature.
    Frutos MC; Origlia J; Gallo Vaulet ML; Venuta ME; García MG; Armitano R; Cipolla L; Madariaga MJ; Cuffini C; Cadario ME;
    Rev Argent Microbiol; 2022; 54(3):247-257. PubMed ID: 35931565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical and epidemiological risk factors of infections due to multi-drug resistant bacteria in an adult intensive care unit of University Hospital Center in Marrakesh-Morocco.
    El Mekes A; Zahlane K; Ait Said L; Tadlaoui Ouafi A; Barakate M
    J Infect Public Health; 2020 Apr; 13(4):637-643. PubMed ID: 31537511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbapenemase-producing Enterobacterales causing secondary infections during the COVID-19 crisis at a New York City hospital.
    Gomez-Simmonds A; Annavajhala MK; McConville TH; Dietz DE; Shoucri SM; Laracy JC; Rozenberg FD; Nelson B; Greendyke WG; Furuya EY; Whittier S; Uhlemann AC
    J Antimicrob Chemother; 2021 Jan; 76(2):380-384. PubMed ID: 33202023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective surveillance of healthcare-associated infections and patterns of antimicrobial resistance of pathogens in an Italian intensive care unit.
    Bianco A; Capano MS; Mascaro V; Pileggi C; Pavia M
    Antimicrob Resist Infect Control; 2018; 7():48. PubMed ID: 29636910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections.
    Gaspari R; Spinazzola G; Teofili L; Avolio AW; Fiori B; Maresca GM; Spanu T; Nicolotti N; De Pascale G; Antonelli M
    Eur J Clin Invest; 2021 Dec; 51(12):e13687. PubMed ID: 34599600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors and effect on mortality of superinfections in a newly established COVID-19 respiratory sub-intensive care unit at University Hospital in Rome.
    Iacovelli A; Oliva A; Siccardi G; Tramontano A; Pellegrino D; Mastroianni CM; Venditti M; Palange P
    BMC Pulm Med; 2023 Jan; 23(1):30. PubMed ID: 36670381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms.
    Neidell MJ; Cohen B; Furuya Y; Hill J; Jeon CY; Glied S; Larson EL
    Clin Infect Dis; 2012 Sep; 55(6):807-15. PubMed ID: 22700828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021).
    Kariyawasam RM; Julien DA; Jelinski DC; Larose SL; Rennert-May E; Conly JM; Dingle TC; Chen JZ; Tyrrell GJ; Ronksley PE; Barkema HW
    Antimicrob Resist Infect Control; 2022 Mar; 11(1):45. PubMed ID: 35255988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infectious Complications in Severe Acute Pancreatitis: Pathogens, Drug Resistance, and Status of Nosocomial Infection in a University-Affiliated Teaching Hospital.
    Tian H; Chen L; Wu X; Li F; Ma Y; Cai Y; Song S
    Dig Dis Sci; 2020 Jul; 65(7):2079-2088. PubMed ID: 31691173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
    Seaton RA; Gibbons CL; Cooper L; Malcolm W; McKinney R; Dundas S; Griffith D; Jeffreys D; Hamilton K; Choo-Kang B; Brittain S; Guthrie D; Sneddon J
    J Infect; 2020 Dec; 81(6):952-960. PubMed ID: 32987097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre- and post-COVID-19 evaluation of antimicrobial susceptibility for healthcare-associated infections in the intensive care unit of a tertiary hospital.
    Gaspar GG; Ferreira LR; Feliciano CS; Campos Júnior CP; Molina FMR; Vendruscolo ACS; Bradan GMA; Lopes NAP; Martinez R; Bollela VR
    Rev Soc Bras Med Trop; 2021; 54():e00902021. PubMed ID: 34320129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Mortality Burden of Multidrug-resistant Pathogens in India: A Retrospective, Observational Study.
    Gandra S; Tseng KK; Arora A; Bhowmik B; Robinson ML; Panigrahi B; Laxminarayan R; Klein EY
    Clin Infect Dis; 2019 Aug; 69(4):563-570. PubMed ID: 30407501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study.
    Siwakoti S; Subedi A; Sharma A; Baral R; Bhattarai NR; Khanal B
    Antimicrob Resist Infect Control; 2018; 7():114. PubMed ID: 30275945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.